Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain protein, Y-linked 23 pseudogene (CDY23P) is a pseudogene on the human Y chromosome. Pseudogenes are nonfunctional segments of DNA resembling functional genes but are generally not transcribed into functional proteins due to disabling mutations such as frameshifts or premature stop codons[8]. The CDY gene family, including functional members like CDY1 and CDY2, are involved in spermatogenesis and may be relevant to male infertility, but the specific member "CDY23P" is classified as a pseudogene and is non-functional[1][8]. Pseudogenes sometimes play minor roles in gene regulation at the RNA level (such as acting as miRNA decoys), but there is no current evidence that CDY23P fulfills such a role, nor is it a known therapeutic target or implicated in any disease[2][3]. There is nothing to suggest the entity "CDY23P" is a protein, receptor, or actionable therapeutic target; it is a non-coding, non-functional genomic sequence typical of Y chromosome pseudogenes[1][8]. If used as a target in a therapeutic or biomarker sense, this would be in error.
Not applicable (CDY23P is not a functional protein or a recognized therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain protein, Y-linked 23 pseudogene (CDY23P).